Upadacitinib (ABT-494) 是一种高效的、具有口服活性的、选择性 Janus 激酶 1 (JAK1) 抑制剂 (IC50=43 nM)。Upadacitinib 对 JAK1 的选择性约为 JAK2 (200 nM)的 74 倍。Upadacitinib 可用于多种自身免疫性疾病的研究。
All
Chemical Reagents
Biomedicine
Organic raw materials
Inorganic chemical industry
intermediate
Agricultural chemicals
Auxiliaries and catalysts
Fragrances and Flavors
Dyes and Pigments
Daily chemical industry
Upadacitinib (ABT-494)
CAS number:1310726-60-3 molecular formula:C17H19F3N6O
overview
compound introduction
Specs
| Chinese alias | - | ||
| English alias | ABT-494 | (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide | 2,2-BIS(4,5-DIMETHYLIMIDAZOLE) | ABBV-599 COMPONENT UPADACITINIB | EX-A1628 | DB15091 | REL-(-)-(3S,4R)-3-ETHYL-4-(3H-IMIDAZO(1,2 | ||
| CAS number | 1310726-60-3 | molecular formula | C17H19F3N6O |
| molecular weight | 380.37 g/mol | Exact mass | - |
| PSA | 78.300 Ų | logp | 2.7 |
numbering system
No numbering system information yet
physicochemical properties
No physical and chemical property information yet
Safety information
No safety information yet
Production methods and uses
No production method and use information yet
Related
upstream information
No upstream information yet
downstream information
No downstream information yet
MSDS
Found 0 shareMSDS





